Comparison between Indo US Bio-Tech IPO and Mahickra Chemicals IPO.
IPO Details
Indo US Bio-Tech IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Mahickra Chemicals IPO is a SME Bookbuilding proposed to list at NSE SME.
Issue Size and Price
The total issue size of Indo US Bio-Tech IPO is up to ₹6.92 Cr whereas the issue size of the Mahickra Chemicals IPO is up to ₹4.98 Cr. The final issue price of Indo US Bio-Tech IPO is ₹51.00 per share and of Mahickra Chemicals IPO is ₹25.00 per share.
IPO Timetable
Indo US Bio-Tech IPO opens on Apr 30, 2018, while Mahickra Chemicals IPO opens on Apr 16, 2018. The closing date of Indo US Bio-Tech IPO and Mahickra Chemicals IPO is May 03, 2018, and Apr 18, 2018, respectively.
| | Indo US Bio-Tech IPO | Mahickra Chemicals IPO |
|---|
| Issue Open | Apr 30, 2018 | Apr 16, 2018 |
| Issue Close | May 03, 2018 | Apr 18, 2018 |
| Basis Of Allotment (Tentative) | May 08, 2018 | Apr 23, 2018 |
| Initiation of Refunds (Tentative) | | Apr 24, 2018 |
| Credit of Share (Tentative) | | Apr 25, 2018 |
| Listing date (Tentative) | May 11, 2018 | Apr 26, 2018 |
Financials & KPIs
Indo US Bio-Tech IPO P/E ratio is , as compared to Mahickra Chemicals IPO P/E ratio of .
Shares Offered
In the Indo US Bio-Tech IPO Retail Individual Investors (RII) are offered 6,78,000 shares while in Mahickra Chemicals IPO retail investors are offered 6,78,000 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Indo US Bio-Tech IPO and 0 shares in Mahickra Chemicals IPO.
| | Indo US Bio-Tech IPO | Mahickra Chemicals IPO |
|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 74,000 shares | 1,08,000 shares |
| QIB | 0 shares | 0 shares |
| NII | 6,78,000 shares | 9,96,000 shares |
| RII | 6,78,000 shares | 9,96,000 shares |
| Employee | 0 shares | 0 shares |
| Total | 13,56,000 shares | 19,92,000 shares |
Bids Received (Subscription)
Indo US Bio-Tech IPO subscribed 19.69x in total, whereas Mahickra Chemicals IPO subscribed 27.85x.
